C

    Co-Diagnostics, Inc. Common Stock (CODX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.24
    +0.03 (+2.48%)

    Market Cap: $8.45M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    45%(14/31)
    Avg Surprise
    -129.85%
    Streak
    1 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-1.25
    Range$-1.25 - $-1.25
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-2.85-128.0%
    60d ago$-3.30-164.0%
    30d ago$-3.30-164.0%
    7d ago$-3.30-164.0%
    Current$-1.25
    Revenue Consensus
    $169000
    Range$169000 - $169000
    1 analysts
    Dec 31, 2026
    EPS Consensus$4.90
    Range$4.90 - $4.90
    1 analysts
    Revenue Consensus
    $188500
    Range$188500 - $188500
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$4.90---
    Sep 26EST
    		-$-1.25---
    Jun 26
    		$-1.46N/A+51.33%Beat+79.2%
    Mar 26
    		$-4.09$-3.75-9.07%Miss+47.0%
    Dec 25
    		$-4.44$-0.13-3314.46%Miss-1074.9%
    Sep 25
    		$-4.66$-5.70+18.25%Beat+52.5%
    Jun 25
    		$-7.01$-7.50+6.53%Beat+6.5%
    Mar 25
    		$-7.72$-9.90+22.02%Beat+21.3%
    Dec 24
    		$-0.38$-0.34-11.12%Miss+24.4%
    Sep 24
    		$-9.82$-9.90+0.81%Beat-50.2%
    Jun 24
    		$-7.50$-10.20+26.47%Beat+21.1%
    Mar 24
    		$-9.81$-6.30-55.71%Miss-42.0%
    Dec 23
    		$-0.50$-0.20-150.00%Miss+26.5%
    Sep 23
    		$-6.54$-8.70+24.83%Beat-174.8%
    Jun 23
    		$-9.50$-7.20-31.94%Miss-226.5%
    Mar 23
    		$-6.91$-7.20+4.03%Beat-190.4%
    Dec 22
    		$-0.68$-0.15-353.33%Miss-372.0%
    Sep 22
    		$-2.38$-1.00-138.00%Miss-120.9%
    Jun 22
    		$-2.91$2.10-238.57%Miss-129.4%
    Mar 22
    		$7.64$5.10+49.80%Beat-2.1%
    Dec 21
    		$0.25$0.12+108.33%Beat-44.4%
    Sep 21
    		$11.40$6.30+80.95%Beat-28.3%
    Jun 21
    		$9.90$6.60+50.00%Beat-23.3%
    Mar 21
    		$7.80$6.00+30.00%Beat+620.0%
    Dec 20
    		$0.45$0.48-6.25%Miss+600.0%
    Sep 20
    		$15.90$21.15-24.82%Miss+630.0%
    Jun 20
    		$12.90$19.50-33.85%Miss+637.5%
    Mar 20
    		$-1.50$-1.20-25.00%Miss+44.4%
    Dec 19
    		$-0.09$-0.09+0.00%Beat+40.0%
    Sep 19
    		$-3.00$-2.25-33.33%Miss-2207.7%
    Jun 19
    		$-2.40$-1.65-45.45%Miss-2081.8%
    Mar 19
    		$-2.70$-2.40-12.50%Miss-2354.5%
    Dec 18
    		$-0.15$-0.13-15.38%Miss-25.0%
    Sep 18
    		$-0.13N/AN/ABeat+60.6%
    Jun 18
    		$-0.11N/AN/ABeat-57.1%
    Mar 18
    		$-0.11N/AN/ABeat-
    Dec 17
    		$-0.12N/AN/ABeat-
    Sep 17
    		$-0.33N/AN/ABeat-
    Jun 17
    		$-0.07$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-0.08EV/EBITDA0.52x
    Price/FCF-0.19xFCF Yield-514.01%
    Profitability
    Profit Margin0.00%Operating Margin-3732.00%
    ROE-174.80%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio1.81xQuick Ratio1.52x
    Trading Statistics
    Beta2.88Avg Volume364.52K
    52-Week High$46.5052-Week Low$0.94

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.21
    SMA 20$1.34
    SMA 50$2.03
    SMA 200$3.83
    EMA 10$1.26
    EMA 20$1.40
    EMA 50$1.97
    EMA 200$4.10

    MACD

    Line: -0.24Signal: -0.30Hist: 0.05

    ADX

    ADX: 21.4+DI: 15.9-DI: 25.5

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down68.0
    PSAR$0.95

    Bollinger Bands

    Upper Band$1.62
    Lower Band$1.06
    %B Position4197%(Upper)
    Band Width0.32

    RSI (14-Day)

    Neutral
    33.7

    Momentum Oscillators

    Stoch %K46.8
    Stoch %D47.3
    Williams %R-52.7
    ROC (10d)-7.5%
    Momentum-0.10
    CCI (20d)-56.7
    MFI (14d)37.8

    Volatility Measures

    ATR (14d)$0.19(15.0%)
    StdDev (20d)0.14
    Hist Vol73.4%(High)

    Volume Flow

    VWAP$1.24
    OBV1.5B
    AD Line265.4B
    CMF (20d)-0.215

    Volume Metrics

    Avg Vol (20d)369.6K
    Vol Ratio0.2x(Low)
    VWMA (20d)$1.31

    Pivot Points

    R3$1.38
    R2$1.33
    R1$1.27
    Pivot Point$1.23
    S1$1.17
    S2$1.12
    S3$1.06

    Advanced Oscillators

    TSI-39.25
    Ultimate Osc39.6
    KST-355.86

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$166,131$145,954$263,922$145,380$162,910$50,277$149,325$641,141$2.66M$467,854$3.56M$2.46M
    Cost of Revenue$45,303$193,768$142,396$26,285$32,106$21,590$255,068$297,403$212,148$234,505$2.97M$255,772
    Gross Profit$120,828$-47,814$121,526$119,095$130,804$28,687$-105,743$343,738$2.44M$233,349$587,336$2.20M
    Operating Expenses$6.32M$9.16M$26.66M$7.13M$8.19M$8.58M$11.80M$10.58M$10.12M$10.49M$12.41M$11.14M
    R&D$4.15M$5.93M$5.10M$4.48M$4.69M$4.87M$4.81M$4.88M$5.61M$5.68M$6.18M$5.79M
    SG&A$1.50M$2.50M$1.87M$1.82M$2.60M$2.77M$5.82M$4.29M$3.13M$2.92M$4.40M$3.15M
    Operating Income$-6,200,783$-9,208,411$-26,541,784$-7,013,848$-8,057,764$-8,551,956$-11,907,024$-10,234,937$-7,679,962$-10,259,387$-11,825,194$-8,935,951
    Interest Income$-34,664$68,893$357,415$-42,765$-1,602$12,157$82,204$264,091$267,685$291,778$439,211$277,012
    Interest Expense$63,835$0$0$39,568$0$0$0$0$0$0$0$0
    Income Before Tax$-6,264,618$-9,139,518$-26,219,441$-7,053,416$-7,717,790$-7,521,267$-11,039,367$-9,674,266$-7,578,728$-9,289,279$-10,842,434$-8,095,775
    Income Tax Expense$19,168$520$-473,716$-1,166,593$12,327$12,004$-8,175$22,189$20,590$22,764$3.83M$-2,113,581
    Net Income$-6,283,786$-9,140,038$-25,745,725$-5,886,823$-7,730,117$-7,533,271$-11,031,192$-9,696,455$-7,599,318$-9,312,043$-14,676,455$-5,982,194
    EBITDA$-6,028,114$-8,952,966$-26,309,290$-6,743,268$-7,424,774$-7,252,979$-10,764,448$-9,587,122$-7,508,078$-9,250,484$-10,968,767$-8,076,447
    EBIT$-6,229,954$-9,208,411$-26,576,856$-7,010,651$-7,716,188$-7,533,424$-11,121,571$-9,938,357$-7,846,413$-9,581,057$-11,281,645$-8,372,787
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CODX

    News

    CODX Forecast — Price Target — Prediction for 2027

    This article provides a forecast for Co-Diagnostics, Inc. (CODX) stock, including analyst price targets and ratings. It details the company's financial performance, stock price changes, market capitalization, and upcoming earnings reports, along with other key financial metrics.

    TradingView•8/21/26•
    Neutral

    ARMISTICE CAPITAL, LLC Buys Co-Diagnostics Inc (CODX) -- Shares Look 33% Undervalued on GF Value

    Armistice Capital, LLC recently acquired a new position of 559,706 shares in Co-Diagnostics Inc (CODX), valuing the transaction at $3.10 per share. Despite this, CODX shares have dropped significantly since the purchase, and the company faces severe financial challenges, including unprofitability and weak growth metrics. While GuruFocus indicates the stock might be 33% undervalued, it also labels it a "Possible Value Trap," cautioning investors due to deteriorating fundamentals.

    GuruFocus•8/21/26•
    Somewhat-Bearish

    Co-Dx (CODX) Q2 2026 Earnings Call Transcript

    Co-Diagnostics (CODX) reported Q2 2026 earnings with a narrowing net loss and reduced operating expenses, driven by lower G&A and R&D costs. The company emphasized its transition from technology development to commercialization, highlighted by the FDA submission for its respiratory multiplex assay and progress in global initiatives for tuberculosis and other infectious diseases. Management is focused on advancing regulatory milestones, expanding global commercial opportunities, and enhancing its integrated molecular diagnostics platform.

    The Globe and Mail•8/21/26•
    Somewhat-Bullish

    Co-diagnostics Company Profile & Introduction

    This document appears to be a company profile and introduction for Co-diagnostics. Without the full content, further details cannot be provided.

    Moomoo•8/20/26•
    Neutral

    Co-Diagnostics Inc (CODX) Stock News Today

    This article provides recent news and financial updates for Co-Diagnostics Inc (CODX). The company's stock price and market capitalization are displayed, along with a link to their latest earnings transcript. The most recent report indicates narrowing losses despite revenue staying near $0.17 million.

    TradingKey•8/18/26•
    Somewhat-Bearish

    Frequently Asked Questions About CODX

    Does CODX pay dividends?
    Co-Diagnostics, Inc. Common Stock (CODX) does not currently pay a regular dividend.
    What is CODX's market cap?
    Co-Diagnostics, Inc. Common Stock (CODX) has a market capitalization of $8.45M with a current stock price of $1.24.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In